{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:50:58Z","timestamp":1787939458721,"version":"build-2784847793"},"reference-count":33,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Children hospitalized for critical asthma (CA) in the pediatric ICU (PICU) are commonly prescribed stress ulcer prophylaxis (SUP) to mitigate risk of gastrointestinal (GI) bleeding. We sought to describe trends for SUP prescribing and explore for differences in rates of GI bleeding, gastritis, and SUP-related complications for those with and without SUP exposure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We performed a retrospective, multicenter cohort study using the Pediatric Hospital Information System registry among 42 children\u2019s hospitals from 2010 to 2019 including children 3 to 17 years of age admitted to the PICU for CA. Primary outcomes were chronologic and regional variation in SUP prescribing assessed by Joinpoint regression and Pearson\u2019s correlation. Rates of GI bleeding, gastritis, enteric ulceration, and SUP-related complications (C. difficile colitis, necrotizing enterocolitis, and thrombocytopenia) were compared for those with and without SUP exposure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Of 30\u2009177 children studied, 10\u2009387 (34.4%) received SUP. No episodes of GI bleeding were recorded. One subject developed gastric ulceration and 32 (0.1%) gastritis. Linear trends for SUP were observed with rates increasing from 25.5% in 2010 to 42.1% in 2019 (+1.9% annually). Prescribing varied by institution (range: 5.5% to 97.2%) without correlation to admission volumes. Extremely rare rates of SUP-related complications were noted.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Although children hospitalized for CA routinely receive SUP, no episodes of GI bleeding were noted over a 10-year period. SUP solely for corticosteroid exposure may be unwarranted. We advocate for a targeted approach to SUP considering alternative risk factors for GI bleeding.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2021-054527","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T08:06:19Z","timestamp":1646121979000},"source":"Crossref","is-referenced-by-count":8,"title":["Stress Ulcer Prophylaxis for Critical Asthma"],"prefix":"10.1542","volume":"149","author":[{"given":"Alexa Rae","family":"Roberts","sequence":"first","affiliation":[{"name":"Divisions of General Pediatrics and Adolescent Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Roddy","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael John","family":"Wilsey","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology, Hepatology, and Nutrition"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott Daniel","family":"McKinley","sequence":"additional","affiliation":[{"name":"Pediatric Pulmonlogy and Sleep Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Sanchez-Teppa","sequence":"additional","affiliation":[{"name":"Pediatric Critical Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony Alexander","family":"Sochet","sequence":"additional","affiliation":[{"name":"Pediatric Critical Care Medicine"},{"name":"Department of Anesthesia and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"issue":"4","key":"2022040103004147100_B1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"4 Pt 1","key":"2022040103004147100_B2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1542\/peds.102.4.933","article-title":"Clinically significant upper gastrointestinal bleeding acquired in a pediatric intensive care unit: a prospective study","volume":"102","author":"Cha\u00efbou","year":"1998","journal-title":"Pediatrics"},{"issue":"1","key":"2022040103004147100_B3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00003246-199201000-00013","article-title":"Frequency of upper gastrointestinal bleeding in a pediatric intensive care unit","volume":"20","author":"Lacroix","year":"1992","journal-title":"Crit Care Med"},{"issue":"7","key":"2022040103004147100_B4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/PCC.0000000000000427","article-title":"Gastric acid suppressant prophylaxis in pediatric intensive care: current practice as reflected in a large administrative database","volume":"16","author":"Costarino","year":"2015","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"2022040103004147100_B5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJM199402103300601","article-title":"Risk factors for gastrointestinal bleeding in critically ill patients","volume":"330","author":"Cook","year":"1994","journal-title":"N Engl J Med"},{"issue":"5","key":"2022040103004147100_B6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00134-015-3725-1","article-title":"Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients","volume":"41","author":"Krag","year":"2015","journal-title":"Intensive Care Med"},{"issue":"6","key":"2022040103004147100_B7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/cc1071","article-title":"The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients","volume":"5","author":"Cook","year":"2001","journal-title":"Crit Care"},{"issue":"2","key":"2022040103004147100_B8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.gtc.2009.03.002","article-title":"Stress-induced ulcer bleeding in critically ill patients","volume":"38","author":"Ali","year":"2009","journal-title":"Gastroenterol Clin North Am"},{"issue":"7","key":"2022040103004147100_B9","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/CCM.0000000000001872","article-title":"Stress ulcer prophylaxis","volume":"44","author":"Barletta","year":"2016","journal-title":"Crit Care Med"},{"issue":"8","key":"2022040103004147100_B10","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1007\/s00134-003-1863-3","article-title":"Clinically significant gastrointestinal bleeding in critically ill patients with and without stress-ulcer prophylaxis","volume":"29","author":"Faisy","year":"2003","journal-title":"Intensive Care Med"},{"issue":"12","key":"2022040103004147100_B11","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1097\/00003246-199912000-00034","article-title":"Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation","volume":"27","author":"Cook","year":"1999","journal-title":"Crit Care Med"},{"issue":"1","key":"2022040103004147100_B12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/PCC.0b013e3181b80e70","article-title":"Stress ulcer, gastritis, and gastrointestinal bleeding prophylaxis in critically ill pediatric patients: a systematic review","volume":"11","author":"Reveiz","year":"2010","journal-title":"Pediatr Crit Care Med"},{"issue":"5","key":"2022040103004147100_B13","doi-asserted-by":"crossref","first-page":"e004587","DOI":"10.1136\/bmjopen-2013-004587","article-title":"Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis","volume":"4","author":"Narum","year":"2014","journal-title":"BMJ Open"},{"issue":"1","key":"2022040103004147100_B14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0037-1607391","article-title":"Diagnosis and management of severe asthma","volume":"39","author":"Chung","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"2022040103004147100_B15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00134-013-3125-3","article-title":"Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis","volume":"40","author":"Krag","year":"2014","journal-title":"Intensive Care Med"},{"issue":"1","key":"2022040103004147100_B16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13643-017-0509-4","article-title":"Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients-protocol for a systematic review with meta-analysis and trial sequential analysis","volume":"6","author":"Marker","year":"2017","journal-title":"Syst Rev"},{"issue":"8","key":"2022040103004147100_B17","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/02770903.2019.1614617","article-title":"Stress ulcer prophylaxis in children with status asthmaticus receiving systemic corticosteroids: a descriptive study assessing frequency of clinically important bleeding","volume":"57","author":"Sochet","year":"2020","journal-title":"J Asthma"},{"issue":"1","key":"2022040103004147100_B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00134-017-5005-8","article-title":"Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials","volume":"44","author":"Alhazzani","year":"2018","journal-title":"Intensive Care Med"},{"issue":"1","key":"2022040103004147100_B19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/09537104.2014.880108","article-title":"Pantoprazole-induced thrombocytopenia in patients with upper gastrointestinal bleeding","volume":"26","author":"Binneto\u011flu","year":"2015","journal-title":"Platelets"},{"issue":"4","key":"2022040103004147100_B20","doi-asserted-by":"crossref","first-page":"696.e11","DOI":"10.1016\/j.jcrc.2014.03.002","article-title":"Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea","volume":"29","author":"Buendgens","year":"2014","journal-title":"J Crit Care"},{"issue":"4","key":"2022040103004147100_B21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5009\/gnl15324","article-title":"Risk of clostridium difficile infection with the use of a proton pump inhibitor for stress ulcer prophylaxis in critically ill patients","volume":"10","author":"Ro","year":"2016","journal-title":"Gut Liver"},{"issue":"1","key":"2022040103004147100_B22","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1542\/peds.2011-0796","article-title":"Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns","volume":"129","author":"Terrin","year":"2012","journal-title":"Pediatrics"},{"issue":"6","key":"2022040103004147100_B23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.5009\/gnl16568","article-title":"Comparison of the hospital-acquired Clostridium difficile infection risk of using proton pump inhibitors versus histamine-2 receptor antagonists for prophylaxis and treatment of stress ulcers: a systematic review and meta-analysis","volume":"11","author":"Azab","year":"2017","journal-title":"Gut Liver"},{"issue":"6","key":"2022040103004147100_B24","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1186\/s13054-014-0714-7","article-title":"Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients","volume":"18","author":"Barletta","year":"2014","journal-title":"Crit Care"},{"issue":"2","key":"2022040103004147100_B25","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1097\/PCC.0000000000002202","article-title":"Stress ulcer prophylaxis in critically ill children: A multicenter observational study","volume":"21","author":"Duffett","year":"2020","journal-title":"Pediatr Crit Care Med"},{"issue":"23","key":"2022040103004147100_B26","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1056\/NEJMoa1714919","article-title":"Pantoprazole in patients at risk for gastrointestinal bleeding in the ICU","volume":"379","author":"Krag","year":"2018","journal-title":"N Engl J Med"},{"key":"2022040103004147100_B27","unstructured":"National Heart Lung and Blood Institute\n          . Guidelines for the diagnosis and management of asthma (EPR3). Available at: https:\/\/www.nhlbi.nih.gov\/health-topics\/guidelines-for-diagnosis-management- of-asthma. Accessed September 1, 2021"},{"issue":"6","key":"2022040103004147100_B28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0961203307079502","article-title":"High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus","volume":"16","author":"Parker","year":"2007","journal-title":"Lupus"},{"issue":"5","key":"2022040103004147100_B29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/chd.12502","article-title":"Kawasaki disease: Medical therapies","volume":"12","author":"Newburger","year":"2017","journal-title":"Congenit Heart Dis"},{"key":"2022040103004147100_B30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2017.03.017","article-title":"Short term outcome of intravenous methylprednisolone pulse therapy in patients with infantile spasms","volume":"71","author":"Yeh","year":"2017","journal-title":"Pediatr Neurol"},{"issue":"1","key":"2022040103004147100_B31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13054-017-1937-1","article-title":"Stress ulcer prophylaxis in intensive care unit patients receiving enteral nutrition: a systematic review and meta-analysis","volume":"22","author":"Huang","year":"2018","journal-title":"Crit Care"},{"issue":"5","key":"2022040103004147100_B32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2217\/cer-2017-0098","article-title":"Comparing efficacy of enteral nutrition plus ranitidine and enteral nutrition alone as stress ulcer prophylaxis","volume":"7","author":"Nourian","year":"2018","journal-title":"J Comp Eff Res"},{"issue":"4","key":"2022040103004147100_B33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/CCM.0000000000000032","article-title":"Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients","volume":"42","author":"MacLaren","year":"2014","journal-title":"Crit Care Med"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-054527\/1275572\/peds_2021054527.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-054527\/1275572\/peds_2021054527.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:04:15Z","timestamp":1648782255000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/149\/4\/e2021054527\/185230\/Stress-Ulcer-Prophylaxis-for-Critical-Asthma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,3,1]]},"published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2021-054527","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]},"article-number":"e2021054527"}}